top of page

The Road to Success is Always Under Construction

About CapsuLINT
CapsuLINT is an Israeli based pharma company that has developed an Oral drug delivery system, designed for facilitated dissolution and potential increased permeability and oral absorption of low solubility drugs and/or low permeability type drugs, in a nano size amorphous dispersion.
Major Milestones
- US Patent granted - Patent No. US 8,187,615 (Application No. 10/585,298) Title: "Non-Aqueous Composition for Oral Delivery of Insoluble Bioactive Agents”
- Docetaxel Clinical Proof of principle PK in rats
Contact information
Allan Aginsky - Co Founder CapsuLINT
Partners500 Contacts
Doron Freidman - Co Founder & CTO CapsuLINT
Alon Blankstein - Co Founder CapsuLINT
bottom of page